about
sameAs
Dopamine D3 and D2 receptor mechanisms in the abuse-related behavioral effects of cocaine: studies with preferential antagonists in squirrel monkeysR-modafinil (armodafinil): a unique dopamine uptake inhibitor and potential medication for psychostimulant abuseThe discriminative stimulus effects of dopamine D2- and D3-preferring agonists in ratsThe binding sites for cocaine and dopamine in the dopamine transporter overlapN-(4-(4-(2,3-dichloro- or 2-methoxyphenyl)piperazin-1-yl)butyl)heterobiarylcarboxamides with functionalized linking chains as high affinity and enantioselective D3 receptor antagonistsDopamine transport inhibitors based on GBR12909 and benztropine as potential medications to treat cocaine addictionAnalogues of the dopamine D2 receptor antagonist L741,626: Binding, function, and SARDiscovery of heterobicyclic templates for novel metabotropic glutamate receptor subtype 5 antagonistsDifferential effects of the dopamine D3 receptor antagonist PG01037 on cocaine and methamphetamine self-administration in rhesus monkeysStructure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective AntagonistThe selective dopamine D3 receptor antagonists SB-277011A and NGB 2904 and the putative partial D3 receptor agonist BP-897 attenuate methamphetamine-enhanced brain stimulation reward in ratsStructure-activity relationship studies on a novel series of (S)-2beta-substituted 3alpha-[bis(4-fluoro- or 4-chlorophenyl)methoxy]tropane analogues for in vivo investigationCharacterization of the transport, metabolism, and pharmacokinetics of the dopamine D3 receptor-selective fluorenyl- and 2-pyridylphenyl amides developed for treatment of psychostimulant abuseNovel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptorDesign and synthesis of a novel photoaffinity ligand for the dopamine and serotonin transporters based on 2beta-carbomethoxy-3beta-biphenyltropane.Structure-activity relationships comparing N-(6-methylpyridin-yl)-substituted aryl amides to 2-methyl-6-(substituted-arylethynyl)pyridines or 2-methyl-4-(substituted-arylethynyl)thiazoles as novel metabotropic glutamate receptor subtype 5 antagonistRhodamine-labeled 2beta-carbomethoxy-3beta-(3,4-dichlorophenyl)tropane analogues as high-affinity fluorescent probes for the dopamine transporter.Dopamine D3 receptors mediate the discriminative stimulus effects of quinpirole in free-feeding rats.Dopamine D(3) receptors contribute to methamphetamine-induced alterations in dopaminergic neuronal function: role of hyperthermia.The N terminus of monoamine transporters is a lever required for the action of amphetaminesStructure-activity relationships in a novel series of 7-substituted-aryl quinolines and 5-substituted-aryl benzothiazoles at the metabotropic glutamate receptor subtype 5Targeting of dopamine transporter to filopodia requires an outward-facing conformation of the transporter.Dopaminergic regulation of dopamine D3 and D3nf receptor mRNA expressionFurther characterization of quinpirole-elicited yawning as a model of dopamine D3 receptor activation in male and female monkeys.Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior.The dopamine D3 receptor partial agonist CJB090 and antagonist PG01037 decrease progressive ratio responding for methamphetamine in rats with extended-access.Structure-Activity Relationships at the Monoamine Transporters for a Novel Series of Modafinil (2-[(diphenylmethyl)sulfinyl]acetamide) Analogues.Synthesis and monoamine transporter binding of 2-(diarylmethoxymethyl)-3 beta-aryltropane derivatives.The neurobiology of modafinil as an enhancer of cognitive performance and a potential treatment for substance use disorders.Computational and biochemical docking of the irreversible cocaine analog RTI 82 directly demonstrates ligand positioning in the dopamine transporter central substrate-binding site.Acute administration of SB-277011A, NGB 2904, or BP 897 inhibits cocaine cue-induced reinstatement of drug-seeking behavior in rats: role of dopamine D3 receptors.Recognition of benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and mazindol as a function of a DAT transmembrane 1 aspartic acid residue.Assessment of the influence of histaminergic actions on cocaine-like effects of 3alpha-diphenylmethoxytropane analogs.N-substituted benztropine analogs: selective dopamine transporter ligands with a fast onset of action and minimal cocaine-like behavioral effectsDissociable control of impulsivity in rats by dopamine d2/3 receptors in the core and shell subregions of the nucleus accumbens.Relationship between conformational changes in the dopamine transporter and cocaine-like subjective effects of uptake inhibitors.Probes for the dopamine transporter: new leads toward a cocaine-abuse therapeutic--A focus on analogues of benztropine and rimcazole.Design and synthesis of substituted N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamides as positive allosteric modulators of the metabotropic glutamate receptor subtype 5.Combinations of cocaine with other dopamine uptake inhibitors: assessment of additivity.N-(3-fluoro-4-(4-(2-methoxy or 2,3-dichlorophenyl)piperazine-1-yl)butyl)arylcarboxamides as selective dopamine D3 receptor ligands: critical role of the carboxamide linker for D3 receptor selectivity.
P50
Q24598398-A082A1EE-B467-401D-AFC2-4B51E50E7A82Q24621917-FC2D2437-F021-4548-B3B9-4B177691237BQ24631461-D251BFE1-AAC7-4EA6-8504-B045CC73B305Q24650126-E00C136C-B5ED-4C70-9484-E4A2FE954BC0Q24653995-26EEB19F-02E0-41B7-BBF0-66A1EAF5E0F7Q24656085-749C32C7-8A52-4677-8DD3-60E008085E04Q24683864-C9D10FB0-A189-4515-A1F4-4863A43A8662Q24684990-98626F86-A9D4-4746-B037-9D55123E2014Q27305163-A22C2F7A-255C-46D7-8356-A6215E1C77DAQ27666030-7AEBA148-B060-4384-8200-D4B2AF40474EQ28256384-72537FA2-4889-48B3-AED9-58F1212B9163Q28267930-94976E02-F5BE-408F-B792-A08B29099E4BQ28275963-CCFBD231-D196-4369-A344-467D3B77F607Q28305618-89658641-B134-4ADB-933E-1858B4B9EDB8Q30357631-9322A8E6-B48D-4539-A037-73B76B539E2BQ30480859-7435A4D5-9CCF-47B5-B485-16FF67E9F8A3Q33227640-159015CD-9B7B-4A4B-B5CB-74040BDB0D20Q33574910-C9FCEE75-0F30-4000-94F3-DD6D865F0AA5Q33768609-DDF5DF41-C70B-4B14-BAA7-33A6D1C69DA4Q33796294-7DD67964-27EE-4C08-B8C1-C770DC0D0FE1Q33856038-9F49A119-DAD1-47B2-8F24-9D5A0C595B98Q33905523-5D69A8E4-C184-44CE-80C0-81EE932DABD0Q33926442-7CC381BB-55C9-435F-A2F2-9B5AE27E0C7CQ33944031-4D2E6CE5-9899-4528-BC80-9F7EE4761475Q33947433-18317967-2A22-421B-AB3F-8882850F5DE3Q33992366-6F1090F9-6BB7-4A57-B514-4ADF586D2D00Q34166309-3418A99E-64AA-41C3-A2BB-F22DEAED5126Q34306632-3EDC96EE-A2AF-43C6-AD25-BC35F65F102BQ34363257-7F602C33-6BD3-4445-B265-070717A8323CQ34396818-5A196FC6-321F-4915-B98C-260891C9FF0EQ34414507-454A86CB-7D9D-493C-A3FA-027BED16A545Q34416712-CF495DDC-0183-43D3-B443-3FE51F6FF8CEQ34438731-02FB054B-3D27-47EB-85B1-2CC9CD7C8756Q34552126-F35F0727-FCEC-4F68-B5BF-D07468295F93Q34660695-80F98DEC-C590-4F2F-AD5C-7732141315FBQ34708664-6347931C-2312-4E3D-81A7-F28B8A553FB7Q34811630-28D574CA-87E8-4ABF-84BB-55954378D79AQ34850993-1703655F-BD20-4566-B761-C355E611CCA0Q34984055-B350F17B-5C07-4BE1-92CA-11C88B98604FQ35001217-1E61FAE7-0DBA-4F28-9AD1-58542A7DE213
P50
description
researcher
@en
wetenschapper
@nl
name
Amy Hauck Newman
@en
Amy Hauck Newman
@es
Amy Hauck Newman
@nl
type
label
Amy Hauck Newman
@en
Amy Hauck Newman
@es
Amy Hauck Newman
@nl
prefLabel
Amy Hauck Newman
@en
Amy Hauck Newman
@es
Amy Hauck Newman
@nl
P21
P31
P496
0000-0001-9065-4072